Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NasdaqCM - Delayed Quote USD

Wellgistics Health, Inc. Common Stock (WGRX)

Compare
3.8100
-0.6900
(-15.33%)
At close: February 21 at 4:00:00 PM EST
3.9300
+0.12
+(3.15%)
After hours: February 21 at 6:51:17 PM EST
Loading Chart for WGRX
DELL
  • Previous Close 4.5000
  • Open 4.3500
  • Bid --
  • Ask --
  • Day's Range 3.3300 - 4.3800
  • 52 Week Range 3.3000 - 4.3800
  • Volume 395,482
  • Avg. Volume 395,600
  • Market Cap (intraday) 197.95M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3500
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

www.wellgisticshealth.com

31

Full Time Employees

December 31

Fiscal Year Ends

Recent News: WGRX

View More

Compare To: WGRX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WGRX

View More

Valuation Measures

Annual
As of 2/21/2025
  • Market Cap

    197.95M

  • Enterprise Value

    219.24M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.60

  • Price/Book (mrq)

    19.82

  • Enterprise Value/Revenue

    3.20

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -62.97%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    5.72M

  • Net Income Avi to Common (ttm)

    -3.6M

  • Diluted EPS (ttm)

    -0.3500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    793.15k

  • Total Debt/Equity (mrq)

    220.58%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: WGRX

View More

Company Insights: WGRX

Research Reports: WGRX

View More

People Also Watch